The landmark SELECT trial significantly expanded the therapeutic paradigm by demonstrating a 20% relative risk reduction in three-point major adverse cardiovascular events (MACEs) with semaglutide 2.4 mg in 17,604 patients with obesity but without diabetes, leading to FDA approval for cardiovascular risk reduction in March 2024 [82]
Erectile responses elicited by cavernous nerve stimulation are increased after i.v.melanotan (MT) -II(1mg/kg), thereby exerting facilitator effect on erection
20 Using the colloid solution albumin to replace volume has many therapeutic effects, including reducing inflammation, accelerating healing, supporting immunomodulation, increasing antioxidant load, and maintaining intravascular colloid osmotic pressure
This precision approach transforms weight loss from one-size-fits-all treatment into personalized therapy grounded in your biology
A drug that increases dopamine can reverse the effects of inflammation on the brain in depression, Emory study shows January 26, 2023 An Emory University study published in Natures Molecular Psychiatry shows levodopa, a drug that increases dopamine in the brain, has potential to reverse the effects of inflammation on brain reward circuitry, ultimately improving symptoms of depression
however, it can cause digestive side effects particularly when introduced too quickly or when doses are too high
